Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03480542 · ClinicalTrials.gov registry record
Central Venous Access Study
A clinical trial of Central Line Catheters, sponsored by Hackensack Meridian Health.
- Completed
- Registry status
- 217
- Enrollment target
- 1
- Study location
NCT03480542 is a study of Central Line Catheters that has completed, run by Hackensack Meridian Health. The registered enrollment target is 217 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03480542, a study of Central Line Catheters, has completed, sponsored by Hackensack Meridian Health.
- COMPLETED
- Registry status
- 217 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to document clinicians variation in practice in comparison to standard guidelines by the Medical Center's approved Evidence-based Practice (EBP) guidelines, policies, and procedures for Central Venous Catheter(CVC), Peripherally Inserted Central Catheter (PICC), and Hemodialysis (HD catheters by way of a structured retrospective review of the Electronic Medical Record (EMR) system.
Conditions Studied
Study Locations (1)
New Jersey
- Hackensack University Medical Center - Hackensack
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 217 participants |
| Start Date | 2017-04-11 |
| Est. Completion | 2022-04-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03480542
The ClinicalTrials.gov registry entry for NCT03480542 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 217 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hackensack Meridian Health, which has 90 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Central Line Catheters appearing as the primary indexed condition, and to 0 interventions.
NCT03480542 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT03480542 about?
NCT03480542 is a clinical study titled "Central Venous Access Study". The aim of this study is to document clinicians variation in practice in comparison to standard guidelines by the Medical Center's approved Evidence-based Practice (EBP) guidelines, policies, and procedures for Central Venous Catheter(CVC), Peripherally Inserted Central Catheter (PICC), and Hemodial...
What is the current status of trial NCT03480542?
This trial is currently completed. The enrollment target is 217 participants. The study started on 2017-04-11. Estimated completion is 2022-04-07.
What conditions does trial NCT03480542 study?
This clinical trial studies the following conditions: Central Line Catheters.
Who is sponsoring clinical trial NCT03480542?
This trial is sponsored by Hackensack Meridian Health, which has 90 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03480542 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.